Search Results - "Salud-Salvia, Antonieta" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

by Morales Murillo, Serafin, Gasol Cudos, Ariadna, Veas Rodriguez, Joel, Canosa Morales, Carles, Melé Olivé, Jordi, Vilardell Villellas, Felip, Sanchez Guzman, Douglas Rene, Iglesias Martínez, Edelmiro, Salud Salvia, Antonieta
Published in Breast (Edinburgh) (01.04.2021)

Get full text

Journal Article

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

by Murillo, Serafin Morales, Cudos, Ariadna Gasol, Rodriguez, Joel Veas, Morales, Carles Canosa, Olivé, Jordi Melé, Villellas, Felip Vilardell, Sanchez Guzman, Douglas Rene, Martínez, Edelmiro Iglesias, Salvia, Antonieta Salud
Published in Future science OA (01.03.2021)

Get full text

Journal Article

Impact of pleural effusion in ovarian cancer: A retrospective study in Lleida, Spain

Impact of pleural effusion in ovarian cancer: A retrospective study in Lleida, Spain

by Murata, Eleonor Paola, Bielsa, Silvia, Pardina, Marina, Salud Salvia, Antonieta, Porcel, Laura, Porcel, Jm
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Determination of endocrine sensitivity by response of the proliferative marker KI67 after short-term preoperative endocrine therapy and their correlation to oncotype score platform

Determination of endocrine sensitivity by response of the proliferative marker KI67 after short-term preoperative endocrine therapy and their correlation to oncotype score platform

by Murillo, Serafin Morales, Gasol Cud"S, Ariadna, Morera Morillo, Ester, Canosa Morales, Carles, Olivé, Jordi Melé, Vilardell Villellas, Felipe, Sánchez Guzmán, Douglas René, Salud Salvia, Antonieta
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Pathological complete response in HER2 positive breast cancer treated with trastuzumab and chemotherapy: Predictive factors report

Pathological complete response in HER2 positive breast cancer treated with trastuzumab and chemotherapy: Predictive factors report

by Gasol Cudós, Ariadna, Morales, Serafin, Novell Alvarez, Anna, Serrate Lopez, Anna, Velasco Sanchez, Ana, Salud Salvia, Antonieta
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

Improving the effectiveness of neoadjuvant chemotherapy in patients with breast cancer with positive estrogen receptor (HR) and HER2 negative

Improving the effectiveness of neoadjuvant chemotherapy in patients with breast cancer with positive estrogen receptor (HR) and HER2 negative

by Morales, Serafin, Gasol Cudós, Ariadna, Cordoba Ortega, Juan Felipe, Panades Siurana, Maria Jose, Vilardell, Felip, Iglesias, Edelmiro, Salud Salvia, Antonieta
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or triplet targeted therapy

Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or triplet targeted therapy

by Ros Montañá, Javier, Martini, Giulia, Baraibar, Iosune, Villacampa, Guillermo, Comas, Raquel, Ciardiello, Davide, Garcia, Ariadna, Hernandez Yague, Xavier, Queralt, Bernardo, Salud Salvia, Antonieta, Argiles, Guillem, Cuadra, Jose Luis, Toledo, Rodrigo A, Chicote, Irene, Mulet, Nuria, Vivancos, Ana, Palmer, Hector G., Dienstmann, Rodrigo, Tabernero, Josep, Elez, Elena
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

Phase III randomized sequential open-label study to evaluate the efficacy of FOLFOX + panitumumab followed by FOLFIRI + bevacizumab (Sequence 1) versus FOLFOX+ bevacizumab followed by FOLFIRI + panitumumab (Sequence 2) in untreated patients with wild-type RAS metastatic, primary left (L)-sided, unresectable colorectal cancer (CRC): The CR-SEQUENCE

Phase III randomized sequential open-label study to evaluate the efficacy of FOLFOX + panitumumab followed by FOLFIRI + bevacizumab (Sequence 1) versus FOLFOX+ bevacizumab followed by FOLFIRI + panitumumab (Sequence 2) in untreated patients with wild-type RAS metastatic, primary left (L)-sided, unresectable colorectal cancer (CRC): The CR-SEQUENCE

by Salazar, Ramon, Carrato, Alfredo, Garcia Garcia, Teresa, Gallego Plazas, Javier, Gómez-España, Auxiliadora, Gravalos Castro, Cristina, Escudero, M. Pilar, Safont, Maria Jose, Salud Salvia, Antonieta, Pericay, Carles, Suárez, Begoña Graña, Marrupe, David, Vidal, Rosario, Losa, Ferran, Fernandez Rodriguez, Teresa, Manzano Mozo, Jose Luis, Tabernero, Josep, Mansinho, Helder, Montagut, Clara, Aranda, Enrique
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs)

Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs)

by Sastre, Javier, Vieitez, Jose María, Gomez-España, Maria Auxilidora, Gil Calle, Silvia, Salud Salvia, Antonieta, Suárez, Begoña Graña, Garcia-Alfonso, Pilar, Martinez de Castro, Eva, Quintero Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González Flores, Encarnación, Fernández, Mercedes Salgado, Guillen, Carmen, Garcia-Carbonero, Rocio, Safont, Maria Jose, La Casta Munoa, Adelaida, García de Paredes, Beatriz, Lopez, Rafael, Aranda, Enrique, Díaz-Rubio, Eduardo
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Randomized phase II study on the influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab (Bev) or cetuximab (Cet), as first line therapy of patients (pts) with RAS wild-type metastatic colorectal carcinoma (mCRC) and <3 baseline circulating tumor cells (bCTCs)

Randomized phase II study on the influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab (Bev) or cetuximab (Cet), as first line therapy of patients (pts) with RAS wild-type metastatic colorectal carcinoma (mCRC) and <3 baseline circulating tumor cells (bCTCs)

by Aranda, Enrique, Garcia-Alfonso, Pilar, Vieitez, Jose María, Ortiz, Maria Jose, López-López, Carlos, Reina-Zoilo, Juan José, Salud Salvia, Antonieta, Quintero Aldana, Guillermo Alfonso, Robles, Luis, Safont, Maria Jose, La Casta Munoa, Adelaida, Alés, Inmaculada, Polo Marques, Eduardo, Gallego Plazas, Javier, García de Paredes, Beatriz, Lopez, Rafael, Mónica, Guillot, Valladares-Ayerbes, Manuel, Sastre, Javier, Díaz-Rubio, Eduardo
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy

Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy

by Marquez-Medina, Diego, Salla-Fortuny, Joel, Salud-Salvia, Antonieta
Published in Clinical & translational oncology (01.12.2012)

Get full text

Journal Article

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

by Valladares-Ayerbes, Manuel, Safont, Maria José, González Flores, Encarnación, García-Alfonso, Pilar, Aranda, Enrique, Muñoz, Ana-Maria López, Falcó Ferrer, Esther, Cirera Nogueras, Luís, Rodríguez-Salas, Nuria, Aparicio, Jorge, Llanos Muñoz, Marta, Pimentel Cáceres, Paola Patricia, Castillo Trujillo, Oscar Alfredo, Vidal Tocino, Rosario, Salgado Fernández, Mercedes, Salud-Salvia, Antonieta, Massuti Sureda, Bartomeu, Garcia-Carbonero, Rocio, Vicente Conesa, Maria Ángeles, Lloansí Vila, Ariadna
Published in Clinical & translational oncology (2024)

Get full text

Journal Article

Safety analysis of a phase III randomized trial comparing FOLFOX + Bevacizumab vs FOLFOXIRI + Bevacizumab as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 circulating tumor cells (CTCs) (VISNÚ-1 TTD TRIAL)

Safety analysis of a phase III randomized trial comparing FOLFOX + Bevacizumab vs FOLFOXIRI + Bevacizumab as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 circulating tumor cells (CTCs) (VISNÚ-1 TTD TRIAL)

by Gomez, A., Vieitez, Jose María, Gil, Silvia, Salud Salvia, Antonieta, Suárez, Begoña Graña, Garcia Alfonso, Pilar, Martínez de Castro, Eva, Quintero Aldana, Guillermo Alfonso, Reina, Juan J, González Flores, Encarnación, Fernández, Mercedes Salgado, Rodríguez Garrote, Mercedes, Flor Oncala, Ma. José, Safont, Maria Jose, La Casta Munoa, Adelaida, Lopez, Rafael, Monica, Guillot, García-Paredes, Beatriz, Diaz-Rubio, Eduardo, Aranda, Enrique
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

by Aranda, Enrique, Viéitez, Jose Maria, Gómez-España, Auxiliadora, Gil Calle, Silvia, Salud-Salvia, Antonieta, Graña, Begoña, Garcia-Alfonso, Pilar, Rivera, Fernando, Quintero-Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González-Flores, Encarnación, Salgado Fernández, Mercedes, Guillén‑Ponce, Carmen, Garcia-Carbonero, Rocio, Safont, María José, La Casta Munoa, Adelaida, García-Paredes, Beatriz, López López, Rafael, Sastre, Javier, Díaz-Rubio, Eduardo
Published in ESMO open (01.01.2020)

Get full text

Journal Article

Induction mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and surgery in high risk rectal cancer: Phase II randomized, multicenter, openlabel trial—The GEMCAD RIA study

Induction mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and surgery in high risk rectal cancer: Phase II randomized, multicenter, openlabel trial—The GEMCAD RIA study

by Fernandez-Martos, Carlos, Alonso, Vicente, Busquier, Isabel, Capdevila, Jaume, Gracian, Antonio Cubillo, Gallego Plazas, Javier, Guasch, Inmaculada, Layos, Laura, Losa, Ferran, Maurel, Juan, Martin-Richard, Marta, Martinez Villacampa, Mercedes, Massuti, Bartomeu, Montagut Viladot, Clara, Nogue, Miquel, Pericay, Carles, Safont, Maria Jose, Salas, Nuria, Salud Salvia, Antonieta, Vera, Ruth
Published in Journal of clinical oncology (20.05.2015)

Get full text

Journal Article

PO142 EVOLUTION OF THE EXPRESSION OF CIRCULATING TUMOR CELLS (CTC) AND CK-19 MRNA (CK19) AS PROGNOSTIC FACTORS IN HEAVILY PRETREATED METASTATIC BREAST CANCER

PO142 EVOLUTION OF THE EXPRESSION OF CIRCULATING TUMOR CELLS (CTC) AND CK-19 MRNA (CK19) AS PROGNOSTIC FACTORS IN HEAVILY PRETREATED METASTATIC BREAST CANCER

by Murillo, Serafín Morales, Sánchez, Ana Velasco, Cudos, Ariadna Gasol, Ortega, Juan Felipe Córdoba, Vidal, Jose, López, Anna Serrate, Valls, Joan, Pérez-Vargas, Juan Carlos Samame, Gisbert, Ramon, Moral, Desamparados, Cussac, Antonio Llombar, Salvia, Antonieta Salud, Guia, Xavier Matias-Guiu
Published in Breast (Edinburgh) (01.11.2015)

Get full text

Journal Article

Correlation of hypertension and proteinuria with outcomes in elderly bevacizumab (BEV)-treated patients with metastatic colorectal cancer (mCRC): Analysis of the BECOX and BECA studies

Correlation of hypertension and proteinuria with outcomes in elderly bevacizumab (BEV)-treated patients with metastatic colorectal cancer (mCRC): Analysis of the BECOX and BECA studies

by Salud Salvia, Antonieta, Feliu, Jaime, Safont, Maria Jose, García-Girón, Carlos, Aparicio, Jorge, Losa, Ferran, Bosch, Carlos, Escudero, Pilar, Casado, Enrique, Jorge Fernández, Mónica, Bohn Sarmiento, Uriel, Pérez-Carrión, Ramon, Carmona Bayonas, Alberto, Custodio, Ana B., Maurel, Juan
Published in Journal of clinical oncology (20.05.2013)

Get full text

Journal Article

Gemcitabine(G)/erlotinib(E) versus gemcitabine/erlotinib/capecitabine(C) in the first-line treatment of patients with metastatic pancreatic cancer (mPC): Efficacy and safety results of a phase IIb randomized study from the Spanish TTD Collaborative Group

Gemcitabine(G)/erlotinib(E) versus gemcitabine/erlotinib/capecitabine(C) in the first-line treatment of patients with metastatic pancreatic cancer (mPC): Efficacy and safety results of a phase IIb randomized study from the Spanish TTD Collaborative Group

by Benavides, Manuel, Gallego Plazas, Javier, Guillen, Carmen, Vera, Ruth, Iranzo, Vega, Diaz, Inmaculada ALES, Arevalo, Sara, Pisa, Aleydis, Martin-Richard, Marta, Salud Salvia, Antonieta, Falco, Esther, Saenz, Alberto, Manzano, Jose Luis, Pulido, Gema, Martínez-Galán, Joaquina, Pazo Cid, Roberto A., Rivera, Fernando, Garcia, Teresa, Irigoyen, Antonio, Aranda, Enrique
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

PR93 CLINICOPATHOLOGICAL EVALUATION OF BRAIN METASTASES RECURRENCE IN METASTATIC HER2+ BREAST CANCER PATIENTS

PR93 CLINICOPATHOLOGICAL EVALUATION OF BRAIN METASTASES RECURRENCE IN METASTATIC HER2+ BREAST CANCER PATIENTS

by Cudós, Ariadna Gasol, Murillo, Serafin Morales, Sánchez, Ana Velasco, López, Ana Serrate, Ortega, Elena Aguirre, Siurana, Maria José Panadés, Salvia, Antonieta Salud
Published in Breast (Edinburgh) (01.11.2013)

Get full text

Journal Article

Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib

Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib

by Márquez-Medina, Diego, Gasol-Cudós, Ariadna, Taberner-Bonastre, M Teresa, Samamé Pérez-Vargas, Juan Carlos, Salud-Salvia, Antonieta, Llombart-Cussac, Antonio
Published in Archivos de bronconeumología (English ed.) (01.02.2013)

Get full text

Journal Article